Package 0363-0691-12

{"route": ["ORAL"], "spl_id": "9dcd6643-9021-4d5a-8d4a-6415e1056e1c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0311917193175"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["f7a5d612-443c-4701-ad3b-8eb53c87bece"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Walgreen Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0363-0691-12)  / 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC", "package_ndc": "0363-0691-12", "marketing_start_date": "20170701"}], "brand_name": "Aspirin 325", "product_id": "0363-0691_9dcd6643-9021-4d5a-8d4a-6415e1056e1c", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0363-0691", "generic_name": "Aspirin", "labeler_name": "Walgreen Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin 325", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20170701", "listing_expiration_date": "20261231"}